<!DOCTYPE article SYSTEM "../../PublishingDTD/source_DTDs/journalpublishing.dtd">
<?mtl hellip?><article><front><journal-meta><journal-id journal-id-type="pmc">jcm</journal-id><journal-id journal-id-type="pubmed">J
Clin Microbiol</journal-id><journal-id journal-id-type="publisher">J CLIN
MICROBIOL</journal-id><issn>0095-1137</issn><publisher><publisher-name>American Society for
Microbiology</publisher-name></publisher></journal-meta><article-meta><article-id
pub-id-type="publisher-id">1435</article-id><article-id
pub-id-type="doi">10.1128/JCM.39.7.2610-2617.2001</article-id><article-id
pub-id-type="pmid">11427578</article-id>
<article-categories><subj-group><subject>Mycobacteriology and Aerobic
Actinomycetes</subject></subj-group></article-categories><title-group><article-title>Detection of
Rifampin-Resistant <italic>Mycobacterium tuberculosis</italic> in Sputa by Nested
PCR-Linked Single-Strand Conformation Polymorphism and DNA
Sequencing</article-title></title-group><contrib-group><contrib
contrib-type="author"><name><surname>Kim</surname><given-names>Bum-Joon</given-names></name><xref
ref-type="aff"><sup>1</sup></xref></contrib><contrib
contrib-type="author"><name><surname>Lee</surname><given-names>Keun-Hwa</given-names></name><xref
ref-type="aff"><sup>2</sup></xref></contrib><contrib
contrib-type="author"><name><surname>Park</surname><given-names>Bo-Na</given-names></name><xref
ref-type="aff"><sup>2</sup></xref></contrib><contrib
contrib-type="author"><name><surname>Kim</surname><given-names>Seo-Jeong</given-names></name><xref
ref-type="aff"><sup>3</sup></xref></contrib><contrib
contrib-type="author"><name><surname>Park</surname><given-names>Eun-Mi</given-names></name><xref
ref-type="aff"><sup>4</sup></xref></contrib><contrib
contrib-type="author"><name><surname>Park</surname><given-names>Young-Gil</given-names></name><xref
ref-type="aff"><sup>4</sup></xref></contrib><contrib
contrib-type="author"><name><surname>Bai</surname><given-names>Gil-Han</given-names></name><xref
ref-type="aff"><sup>4</sup></xref></contrib><contrib
contrib-type="author"><name><surname>Kim</surname><given-names>Sang-Jae</given-names></name><xref
ref-type="aff"><sup>4</sup></xref></contrib><contrib
contrib-type="author"><name><surname>Kook</surname><given-names>Yoon-Hoh</given-names></name><xref
ref-type="aff"><sup>2</sup></xref><xref ref-type="author-notes"
rid="FN150">&#x002A;</xref></contrib></contrib-group><aff><sup>1</sup>Department of
Microbiology, Cheju National University College of Medicine, Cheju
690-756,<sup>1</sup><sup>2</sup> Department of Microbiology and Institute of
Endemic Diseases, Medical Research Center, Seoul National University College of
Medicine, and Clinical Research Institute, Seoul National University Hospital,
Seoul 110-799,<sup>2</sup><sup>3</sup> Department of Pediatrics, Pundang CHA
General Hospital, Pochun CHA Medical School, Kyonggi Sungnam
463-670,<sup>3</sup> and <sup>4</sup>The Korean Institute of Tuberculosis, the
Korean National Tuberculosis Association, Seoul 137-140,<sup>4</sup>
Korea</aff><author-notes><fn id="FN150"><p>Corresponding author.
Mailing address: Department of Microbiology, Seoul National University College
of Medicine, 28 Yongon-Dong, Chongno-Gu, Seoul 110-799, Korea. Phone:
82-2-740-8306. Fax: 82-2-743-0881. E-mail:
<email>yhkook@plaza.snu.ac.kr</email>.</p></fn></author-notes><pub-date
pub-type="pub"><day>1</day><month>7</month><year>2001</year></pub-date><volume>39
</volume><issue>7</issue><fpage>2610</fpage><lpage>2617</lpage><history><date
date-type="received"><day>6</day><month>11</month><year>2000</year></date><date
date-type="rev-request"><day>4</day><month>2</month><year>2001</year></date>
<date
date-type="accepted"><day>26</day><month>4</month><year>2001</year></date>
</history><copyright-statement>Copyright &#x00A9; 2001, American Society for
Microbiology</copyright-statement>
<copyright-year>2001</copyright-year>
<abstract><p>Either PCR-mediated single strand conformation
polymorphism (SSCP) analysis or DNA sequencing of <italic>rpoB</italic> DNA (157 bp) can
be used as a rapid screening method for the detection of mutations related to
the rifampin resistance of <italic>Mycobacterium tuberculosis</italic>. However, due to
the nonspecific amplification of <italic>rpoB</italic> DNA from nontuberculous
mycobacteria these methods cannot be directly applied to clinical specimens such
as sputa. We developed a nested PCR method that can specifically amplify the
<italic>rpoB</italic> DNA of <italic>M. tuberculosis</italic> on the basis of <italic>rpoB</italic> DNA
sequences of 44 mycobacteria. Nested PCR-linked SSCP analysis and the DNA
sequencing method were applied directly in order to detect <italic>M.
tuberculosis</italic> and determine its rifampin susceptibility in 56 sputa. The
results obtained by nested PCR-SSCP and DNA sequencing were concordant with
those of conventional drug susceptibility testing and DNA sequencing performed
with culture
isolates.</p></abstract></article-meta></front><body><sec><title>Introduction</title><p><italic>
Mycobacterium tuberculosis</italic> is still regarded as a causative agent of high
morbidity and mortality throughout the world (<xref ref-type="bibr"
rid="B5">5</xref>). Due to the spread of human immunodeficiency virus infection,
the decline in the incidence of tuberculosis which had been brought about by
advanced antituberculosis chemotherapy and improved living conditions was
reversed in the mid-1980s. Human immunodeficiency virus-related tuberculosis led
to a rise in the frequency of multidrug-resistant <italic>M. tuberculosis</italic>
(<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr"
rid="B7">7</xref>). The rapid detection of resistance to first-line drugs such
as rifampin and isoniazid is essential for the efficient control of
multidrug-resistant strains (<xref ref-type="bibr" rid="B3">3</xref>, <xref
ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B16">16</xref>).
Although the period required for culturing is shortened by the BACTEC system,
drug susceptibility testing in a liquid medium still requires 1 to 2 weeks for
final determination and report to the clinicians (<xref ref-type="bibr"
rid="B19">19</xref>), calling for further reduction of the detection
period.</p><p>Recently, molecular methods exploiting the genetic mechanism of
drug resistance have markedly improved the diagnosis of drug-resistant
tuberculosis (<xref ref-type="bibr" rid="B17">17</xref>, <xref ref-type="bibr"
rid="B20">20</xref>). Rifampin resistance of <italic>M. tuberculosis</italic> is largely
associated with point mutations in a region of <italic>rpoB</italic> (<xref
ref-type="bibr" rid="B20">20</xref>), mutations which cause rifampin resistance
to a high level in <italic>Escherichia coli</italic> (<xref ref-type="bibr"
rid="B10">10</xref>, <xref ref-type="bibr" rid="B14">14</xref>). Various
molecular methods have been applied to detect these unique mutations, including
PCR-mediated single-strand conformation polymorphism (SSCP) analysis (<xref
ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B15">15</xref>,
<xref ref-type="bibr" rid="B21">21</xref>), single-tube heminested PCR-SSCP
(<xref ref-type="bibr" rid="B23">23</xref>), the dideoxy fingerprinting method
(<xref ref-type="bibr" rid="B6">6</xref>), line probe assay (<xref
ref-type="bibr" rid="B4">4</xref>), and DNA sequence analysis (<xref
ref-type="bibr" rid="B11">11</xref>, <xref ref-type="bibr" rid="B20">20</xref>).
For the rapid detection or determination of rifampin resistance, it is desirable
to apply these methods directly to primary specimens, such as sputa, as well as
cultures. Among these methods, PCR-SSCP may be the most cost-effective method
for detecting point mutations within the 69-nucleotide region. However, the
direct detection of rifampin-resistant <italic>M. tuberculosis</italic> in sputa by
conventional PCR-SSCP has a drawback in that it lacks sensitivity. Nonspecific
amplification due to the highly conserved sequences of <italic>rpoB</italic> DNA among
GC-rich bacteria that may reside in the respiratory tract has led to difficulty
in interpreting PCR-SSCP results (<xref ref-type="bibr" rid="B21">21</xref>).
For this reason, earlier studies using this technique required the use of pure
cultures of <italic>M. tuberculosis</italic>. To resolve these problems, a heminested
PCR method based on <italic>M. tuberculosis</italic> signature nucleotides was
introduced (<xref ref-type="bibr" rid="B23">23</xref>). Although heminested PCR
was effective in amplifying <italic>M. tuberculosis</italic>-specific <italic>rpoB</italic> DNA
directly from sputum samples, applying this method to SSCP analysis could not
resolve mutations at codon 526 (in <italic>E. coli</italic> numbering). Furthermore,
when compared with the conventional PCR-SSCP analysis of 157-bp DNA, this method
required a longer electrophoresis time for the clear differentiation of bands in
several resistant strains (<xref ref-type="bibr" rid="B6">6</xref>).</p><p>In
this study, we developed a nested PCR that can specifically amplify the
<italic>rpoB</italic> DNA of <italic>M. tuberculosis</italic>. Based on the 44 <italic>rpoB</italic>
sequences of mycobacteria (<xref ref-type="bibr" rid="B11">11</xref>), we were
able to design <italic>M. tuberculosis</italic>-specific primers for nested PCR. Nested
PCR-linked SSCP analysis and a direct DNA sequencing method were applied to
detect mutations of <italic>M. tuberculosis</italic> in sputa. This enabled us to detect
mutations related to rifampin resistance occurring within the 69-nucleotide
region of <italic>rpoB</italic> DNA derived from 56 sputa. The results were compared
with those obtained by conventional PCR-SSCP, drug susceptibility testing, and
the DNA sequence analysis of cultured <italic>M. tuberculosis</italic> from the same
sputum samples.</p></sec><sec sec-type="materials/methods"><title>MATERIALS AND
METHODS</title><sec><title>Mycobacteria and DNA
preparation.</title><p>Twenty-eight reference strains (19 strains of
mycobacteria and 9 strains of nonmycobacteria) and 48 clinical isolates of
mycobacteria that had been isolated from patients with mycobacterial infections
were used to determine the specificity of a first-round PCR (Table <xref
ref-type="table" rid="T1">1</xref>). Fifty-six sputum specimens from patients with
suspected <italic>M. tuberculosis</italic> infections and <italic>M. tuberculosis</italic>
isolates from culture of the same specimens were provided by the Korean
Institute of Tuberculosis for the nested PCR-linked SSCP and direct sequencing.
Amplification of <italic>IS6110</italic> DNAs (536 bp) and positive cultures also
supported the presence of <italic>M. tuberculosis</italic> in all of the sputa. Clinical
isolates were identified by conventional biochemical tests and partial 16S rDNA
sequencing.</p><table-wrap id="T1"><caption><p>Mycobacteria and
nonmycobacteria used to determine the specificity of the first-round PCR
</p></caption><table><tr><th>Species</th><th>Type strains<xref ref-type="table-fn"
rid="TF1-A"></xref></th><th>No. of clinical isolates<xref ref-type="table-fn"
rid="TF1-B"></xref></th></tr><tr><td
colspan="3"><hr/></td></tr><tr><td>Mycobacteria</td><td/><td/></tr><tr>
<td>&#x2003;<italic>M. avium</italic></td><td align="left">ATCC 25291</td><td>6
</td></tr><tr><td>&#x2003;<italic>M. fortuitum</italic></td><td align="left">ATCC
6841</td><td>4 </td></tr><tr><td>&#x2003;<italic>M. gordonae</italic></td><td
align="left">ATCC 14470</td><td>2 </td></tr><tr><td>&#x2003;<italic>M.
kansasii</italic></td><td align="left">ATCC
12478</td><td>5</td></tr><tr><td>&#x2003;<italic>M. nonchromogenicum</italic></td><td
align="left">ATCC 19530</td><td>0 </td></tr><tr><td>&#x2003;<italic>M.
scrofulaceum</italic></td><td align="left">ATCC 19981</td><td>0
</td></tr><tr><td>&#x2003;<italic>M. smegmatis</italic></td><td align="left">ATCC
19420</td><td>0 </td></tr><tr><td>&#x2003;<italic>M. terrae</italic></td><td
align="left">ATCC 15755</td><td>0 </td></tr><tr><td>&#x2003;<italic>M.
triviale</italic></td><td align="left">ATCC
23292</td><td>0</td></tr><tr><td>&#x2003;<italic>M. vaccae</italic></td><td
align="left">ATCC 15483</td><td>0 </td></tr><tr><td>&#x2003;<italic>M.
chelonae</italic></td><td align="left">ATCC 35749</td><td>3
</td></tr><tr><td>&#x2003;<italic>M. gastri</italic></td><td align="left">ATCC
15754</td><td>0 </td></tr><tr><td>&#x2003;<italic>M. intracellulare</italic></td><td
align="left">ATCC 13950</td><td>8</td></tr><tr><td>&#x2003;<italic>M.
malmoense</italic></td><td align="left">ATCC 29571</td><td>0
</td></tr><tr><td>&#x2003;<italic>M. phlei</italic></td><td align="left">ATCC
11758</td><td>0 </td></tr><tr><td>&#x2003;<italic>M. simiae</italic></td><td
align="left">ATCC 25275</td><td>0 </td></tr><tr><td>&#x2003;<italic>M.
szulgai</italic></td><td align="left">ATCC
35799</td><td>0</td></tr><tr><td>&#x2003;<italic>M. tuberculosis</italic></td><td
align="left">ATCC 27294</td><td>20 </td></tr><tr><td>&#x2003;<italic>M.
ulcerans</italic></td><td align="left">ATCC
19423</td><td>0</td></tr><tr><td>Nonmycobacteria</td><td
align="left"/><td/></tr><tr><td>&#x2003;<italic>Rhodococcus equi</italic></td><td
align="left">IMSNU20114</td><td>0 </td></tr><tr><td>&#x2003;<italic>Rhodococcus
erythropolis</italic></td><td align="left">IMSNU20115</td><td>0
</td></tr><tr><td>&#x2003;<italic>Rhodococcus rhodochrous</italic></td><td
align="left">IMSNU20349</td><td>0 </td></tr><tr><td>&#x2003;<italic>Nocardia
otitidiscaviarum</italic></td><td align="left">IMSNU21221</td><td>0
</td></tr><tr><td>&#x2003;<italic>Nocardia nova</italic></td><td
align="left">IMSNU21197</td><td>0 </td></tr><tr><td>&#x2003;<italic>Corynebacterium
diphtheriae</italic></td><td align="left">MSNU</td><td>0
</td></tr><tr><td>&#x2003;<italic>Corynebacterium glutamicum</italic></td><td
align="left">IMSNU21196</td><td>0 </td></tr><tr><td>&#x2003;<italic>Neisseria
meningitidis</italic></td><td align="left">MSNU</td><td>0
</td></tr><tr><td>&#x2003;<italic>Haemophilus influenzae</italic></td><td
align="left">MSNU</td><td>0</td></tr></table><table-wrap-foot><fn id="TF1-A"><p>MSNU,
Department of Microbiology, Seoul National University College of Medicine;
IMSNU, Institute of Microbiology, Seoul National University.</p></fn><fn
id="TF1-B"><p>Clinical isolates were identified by biochemical tests and partial
16S rDNA sequencing.</p></fn></table-wrap-foot></table-wrap><p>DNAs were purified by a
previously described method (<xref ref-type="bibr" rid="B2">2</xref>, <xref
ref-type="bibr" rid="B11">11</xref>). A loopful culture of each strain was
suspended with 200 &#x03BC;l of TEN buffer (10 mM Tris-HCl, 1 mM EDTA, 100 mM
NaCl &#x005B;pH 8.0&#x005D;) and placed in a 2.0-ml screw-cap microcentrifuge
tube filled with 100 &#x03BC;l (packed volume) of glass beads (diameter, 0.1 mm;
Biospec Products, Bartlesville, Okla.), and then 200 &#x03BC;l of
phenol-chloroform-isoamylalcohol (50:49:1) was added to this mixture. The
screw-cap tube filled with the mixture was oscillated on a Mini-Bead beater
(Biospec Products) for 1 min to disrupt the bacteria. The tube was centrifuged
(12,000 &#x00D7; <italic>g</italic>, 5 min), and the aqueous phase was transferred into
another clean tube, to which 10 &#x03BC;l of 3 M sodium acetate and 130
&#x03BC;l of isopropyl alcohol were added. The DNA pellet was washed with
70&#x0025; ethanol and solubilized with 60 &#x03BC;l of TE buffer (10 mM
Tris-HCl, 1 mM EDTA, pH 8.0). Two microliters of purified DNA was used as the
template in the PCRs. The sputa were processed by 1&#x0025; NaOH for
liquefaction-decontamination and sedimentation (12,000 &#x00D7; <italic>g</italic>, 15
min) (<xref ref-type="bibr" rid="B18">18</xref>). The sediments were resuspended
in 1.5 ml of phosphate buffer (pH 6.8) and 0.5 ml was inoculated onto
L&#x00F6;wenstein-Jensen media. DNAs were isolated from the residual sediments
(1.0 ml) of smear-positive sputa as above and dissolved in 60 &#x03BC;l of TE
buffer (pH 8.0). Two microliters of prepared DNA in TE buffer was used as the
template in both the conventional PCR and the nested
PCR.</p></sec><sec><title>Identification and rifampin susceptibility testing of
<italic>M. tuberculosis</italic>.</title><p>Clinical isolates of <italic>M.
tuberculosis</italic> were tested at the Korean Institute of Tuberculosis for drug
susceptibility by agar dilution (1&#x0025; proportion method) (<xref
ref-type="bibr" rid="B13">13</xref>). Fifty-six sputa and the above-mentioned
clinical isolates underwent nested PCR-SSCP and sequencing without prior
information as to their rifampin susceptibility. Separate PCRs (<xref
ref-type="bibr" rid="B22">22</xref>) were performed on these specimens to detect
and identify <italic>M. tuberculosis</italic> in both sputa and cultures using an
<italic>IS6110</italic> kit (catalog no. N5811; Bioneer, Chungbuk, Korea) according to
the manufacturer's instruction.</p></sec><sec><title>Conventional PCR-linked
SSCP and DNA sequencing.</title><p>Conventional PCR-SSCP was performed as
previously described, using TR9 and TR8 primers (<xref ref-type="bibr"
rid="B12">12</xref>, <xref ref-type="bibr" rid="B21">21</xref>). Separately, 56
culture isolates of <italic>M. tuberculosis</italic> derived from the same specimens
were analyzed by conventional PCR-DNA sequencing. The amplified products were
purified by QIAEX II gel elution system (QIAGEN, Hilden, Germany). Nucleotide
sequences were directly determined from the purified PCR product (157 bp) with
forward and reverse primers using an Applied Biosystems 373A automatic sequencer
and BigDye Terminator Cycle Sequencing kit (PE Applied Biosystems, Warrington,
United Kingdom). For the sequencing reaction, 60 ng of PCR-amplified DNA, 3.2
pmol of either the forward or the reverse primer and 8 &#x03BC;l of BigDye
Terminator RR mix (part no. 4303153; PE Applied Biosystems) were mixed and
adjusted to a final volume of 20 &#x03BC;l by adding distilled water. The
reaction was run using 5&#x0025; (vol/vol) dimethylsulfoxide for 30 cycles of 15
s at 95&#x00B0;C, 10 s at 50&#x00B0;C, and 4 min at 60&#x00B0;C. Both strands
were sequenced for cross check.</p></sec><sec><title>Nested PCR-linked SSCP and
DNA sequencing.</title><p><italic>M. tuberculosis</italic>-specific nucleotides have
been found in the <italic>rpoB</italic> sequences (<xref ref-type="bibr"
rid="B8">8</xref>, <xref ref-type="bibr" rid="B11">11</xref>). The outer primers
TB1 (5&#x2032;-<bold>A</bold>CGTGGAGGCGATCACACCGCAGACGT-3&#x2032;) and TB2
(5&#x2032;-TGCACGTCGCGGACCTCCA<bold>GCCCGGCA</bold>-3&#x2032;) were modified from
<italic>Rpo</italic>105 (<xref ref-type="bibr" rid="B23">23</xref>) and TR8,
respectively (<xref ref-type="bibr" rid="B21">21</xref>) (modifications are in
bold). The inner primers for the second-round PCR were TB3
(5&#x2032;-TCGCCGCGATCAAGGAGT<bold>TCTTC</bold>-3&#x2032;), which was modified from
TR9, and TR8 (<xref ref-type="bibr" rid="B21">21</xref>) (Fig. <xref
ref-type="fig" rid="F1">1</xref>). The first-round PCR was performed in a
20-&#x03BC;l PCR mixture tube (AccuPower PCR PreMix; Bioneer) containing 2 U of
<italic>Taq</italic> polymerase, 10 mM Tris-HCl (pH 8.3), and 1.5 mM MgCl<sub>2</sub>,
and 20 pmol of each primer was added. The volume was adjusted to 20 &#x03BC;l.
The reaction mixture was subjected to 30 cycles of amplification (30 s at
95&#x00B0;C, 60 s at 78&#x00B0;C) followed by a 5-min extension at 78&#x00B0;C
in a Perkin-Elmer Cetus Model 9600 thermalcycler. The first-round PCR product
(205 bp) was diluted (100-fold) and used as a template for the second-round PCR
(157 bp), which was performed in 30 cycles (30 s at 95&#x00B0;C, 1 min at
72&#x00B0;C) followed by a 5-min extension at 72&#x00B0;C. SSCP analysis was
performed as described above, except that 0.1 &#x03BC;l (0.1 &#x03BC;Ci) of
&#x005B;&#x03B1;-<sup>32</sup>P&#x005D;dCTP (Amersham International) was added
to the second reaction mixture. DNA sequencing was directly performed with
nested PCR products as above.</p><fig id="F1"><caption><p>Primers used for PCR and nested PCR. Conventional PCR was
performed with the TR9-TR8 primer set as previously described. The first-round
PCR was performed with the TB1-TB2 primer set amplifying 205-bp <italic>rpoB</italic>
DNA. The second-round PCR was performed with the TB3-TR8 primer set to amplify
157-bp DNA from the first-round PCR product. Numbers indicate <italic>rpoB</italic>
codons of <italic>E. coli</italic>.</p></caption><graphic
xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jm0711435001"
alt-version="yes"></graphic></fig></sec><sec><title>Southern
blotting.</title><p>First-round PCR products were electrophoresed on a
1.5&#x0025; (wt/vol) agarose gel (Sigma, Steinheim, Germany). The DNA on agarose
gel was denatured with a solution of 1.5 M NaCl and 0.5 N NaOH and neutralized
with a solution of 1 M Tris (pH 7.4) and 1.5 M NaCl. Subsequently, the denatured
DNA was transferred to nylon membranes (Nytran 77593; Schleicher &#x0026;
Schuell, Inc., Keene, N.H.) by the capillary transfer method. The membranes were
hybridized with <sup>32</sup>P-labeled 157-bp <italic>rpoB</italic> fragment probes,
which were amplified by PCR using the TR9-TR8 primer set from <italic>Mycobacterium
avium</italic> (ATCC 25291). The random primer labeling kit (Amersham, Arlington
Heights, Ill.) was used for radiolabeling. Hybridization was performed at
68&#x00B0;C with a solution containing 6&#x00D7; SSC (1&#x00D7; SSC is 0.15 M
NaCl plus 0.015 M sodium citrate) 0.5&#x0025; sodium dodecyl sulfate, 100
&#x03BC;g of salmon sperm DNA per ml, and 5&#x00D7; Denhardt solution. The
membrane was washed twice at 65&#x00B0;C with a solution of 2&#x00D7; SSC and
0.1&#x0025; sodium dodecyl sulfate for 30 min.</p></sec></sec><sec
sec-type="results"><title>RESULTS</title><sec><title>Amplification of <italic>rpoB</italic>
DNA by nested PCR.</title><p>The PCR product amplified by the first-round PCR
(TB1-TB2 primer set) was 205-bp <italic>rpoB</italic> DNA comprising a 157-bp fragment
which was previously used for SSCP analysis (<xref ref-type="bibr"
rid="B12">12</xref>, <xref ref-type="bibr" rid="B15">15</xref>, <xref
ref-type="bibr" rid="B21">21</xref>). The specificity of the first-round PCR was
tested with the DNAs from the reference strains of 19 mycobacteria and 9
nonmycobacteria and 48 clinical isolates of mycobacteria. The products were
amplified only from the type strain and 20 clinical isolates of <italic>M.
tuberculosis</italic>. The specificity of the first-round PCR was verified by
Southern blotting (Fig. <xref ref-type="fig" rid="F2">2</xref>). Nothing was
amplified when the template DNAs were diluted to less than 10 fg. Thus, the
sensitivity of nested PCR assay in terms of DNA amount in a reaction could be
determined as 10 fg of DNA in ethidium bromide-stained gels (Fig. <xref
ref-type="fig" rid="F3">3</xref>).</p><fig id="F2"><caption><p>Specific amplification of <italic>M. tuberculosis rpoB</italic> DNA
by first-round PCR (TB1-TB2 primer set). The Southern blot shows that the PCR
product (205 bp) was amplified from only <italic>M. tuberculosis</italic> by the
first-round PCR. (A and B) Lanes: 1, <italic>M. tuberculosis</italic> H37Rv; 2, clinical
isolate of <italic>M. tuberculosis</italic>; M, &#x03C6;X174/RF DNA/<italic>Hae</italic>III
digest; 3, <italic>M. avium</italic>; 4, <italic>M. fortuitum</italic>; 5, <italic>M. gastri</italic>;
6, <italic>M. gordonae</italic>; 7, <italic>M. intracellulare</italic>; 8, <italic>M. kansasii</italic>;
9; <italic>M. malmoense</italic>; 10, <italic>M. nonchromogenicum</italic>; 11, <italic>M.
phlei</italic>; 12, <italic>M. scrofulaceum</italic>; 13, <italic>M. simiae</italic>; 14, <italic>M.
smegmatis</italic>; 15, <italic>M. terrae</italic>. (C and D) Lanes 16, <italic>M.
triviale</italic>; 17, <italic>M. vaccae</italic>; 18, <italic>M. chelonae</italic>; 19, <italic>M.
szulgai</italic>; 20, <italic>M. ulcerans</italic>; 21, <italic>Rhodococcus equi</italic>; 22,
<italic>Rhodococcus erythropolis</italic>; 23, <italic>Rhodococcus rhodochrous</italic>; 24,
<italic>Nocardia otitidiscaviarum</italic>; 25, <italic>Nocardia nova</italic>; 26,
<italic>Corynebacterium glutamicum</italic>; 27, <italic>Corynebacterium diphtheriae</italic>;
28, <italic>Neisseria meningitidis</italic>; 29, <italic>Haemophilus
influenzae</italic>.</p></caption><graphic
xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jm0711435002"
alt-version="yes"></graphic></fig><fig id="F3"><caption><p>Amplification of <italic>rpoB</italic> DNA by nested PCR using
serially diluted <italic>M. tuberculosis</italic> DNA as templates. Amplified products
are observed only in the lanes that used more than 10 fg of template DNA. Lanes:
M, &#x03C6;X174/RF DNA/<italic>Hae</italic>III digest; 1, 10 ng; 2, 1 ng; 3, 100 pg; 4,
10 pg; 5, 1 pg; 6, 100 fg; 7, 10 fg; 8, 1 fg; 9, negative control without
DNA.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink"
xlink:href="jm0711435003"
alt-version="yes"></graphic></fig></sec><sec><title>PCR- and nested PCR-SSCP
analysis for sputa.</title><p>When conventional PCR-SSCP using the TR9-TR8
primer set was directly applied to sputa, rifampin susceptibility of 11 of 56
samples could not be determined (Table <xref ref-type="table" rid="T2">2</xref>).
The targeted <italic>rpoB</italic> DNAs were rarely amplified from eight sputum
specimens (N2895, N2994, N3440, N3448, N3903, N3912, N3990, and N4064). Three
sputum specimens (N3104, N3928, and N3983) showed ambiguous SSCP patterns
displaying more than three bands, which was possibly caused by simultaneous
amplification of the <italic>rpoB</italic> DNA from both <italic>M. tuberculosis</italic> and
other bacteria. Furthermore, one (N3928) of these three sputum specimens showed
a false-positive PCR-SSCP result. Because the SSCP pattern differed from that of
the rifampin-susceptible reference strain, it was identified as a
rifampin-resistant strain (Fig. <xref ref-type="fig" rid="F4">4</xref>). In
contrast, the nested PCR successfully produced a 157-bp DNA directly from all of
the specimens. Therefore, the presence of mutations in the amplified
<italic>rpoB</italic> DNA from all specimens could be determined easily by SSCP analysis
(Tables <xref ref-type="table" rid="T2">2</xref> and <xref ref-type="table"
rid="T3">3</xref>). Typical SSCP patterns of <italic>M. tuberculosis rpoB</italic> DNA
were observed (Fig. <xref ref-type="fig" rid="F4">4</xref>). The three sputum
specimens that had shown ambiguous results by conventional PCR-SSCP analysis
were clearly determined to be two rifampin-resistant strains (N3104 and N3983)
and one susceptible strain (N3928) of <italic>M. tuberculosis</italic> by nested
PCR-SSCP analysis (Fig. <xref ref-type="fig" rid="F4">4</xref>), susceptibility
testing, and PCR direct sequencing of <italic>rpoB</italic> DNA from the culture (Table
<xref ref-type="table" rid="T3">3</xref>). The results of the nested PCR-SSCP
method performed on sputum specimens were entirely concordant with those of
cultures analyzed by drug susceptibility testing and conventional PCR-SSCP.
Based on the result of susceptibility testing performed with cultures,
conventional PCR-SSCP analysis for sputa showed only 75.8&#x0025; sensitivity
and 87&#x0025; specificity (Table <xref ref-type="table" rid="T2">2</xref>).
</p><table-wrap id="T2"><caption><p>Rifampin susceptibility of
<italic>M. tuberculosis</italic> in sputa determined by conventional PCR-SSCP and nested
PCR-SSCP analyses</p></caption><table><tr><th rowspan="3">Method</th><th
rowspan="3">Result</th><th colspan="2">No. of sputum samples found by rifampin
susceptibility testing<xref ref-type="table-fn" rid="TF2-A"></xref> to be:
</th></tr><tr><td colspan="2"><hr/></td></tr><tr><th>Susceptible (<italic>n</italic> =
33)</th><th>Resistant (<italic>n</italic> = 23)</th></tr><tr><td
colspan="4"><hr/></td></tr><tr><td>PCR-SSCP</td><td
align="left">Susceptible</td><td>25</td><td>0</td></tr><tr><td/><td
align="left">Resistant</td><td>0</td><td>20 </td></tr><tr><td/><td
align="left">Not determined<xref ref-type="table-fn"
rid="TF2-B"></xref></td><td>8</td><td>3 </td></tr><tr><td rowspan="2">Nested
PCR-SSCP and DNA sequencing</td><td
align="left">Susceptible</td><td>33</td><td>0</td></tr><tr><td
align="left">Resistant</td><td>0</td><td>23 </td></tr><tr><td/><td
align="left">Not determined</td><td>0</td><td>0</td></tr></table><table-wrap-foot><fn
id="TF2-A"><p>Agar dilution method performed with cultures from the same sputa
used for SSCP analysis.</p></fn><fn id="TF2-B"><p>SSCP patterns could not be
interpreted due to no amplification or more than three
bands.</p></fn></table-wrap-foot></table-wrap><fig id="F4"><caption><p>Comparison of PCR-SSCP and nested PCR-SSCP performed with
three sputum specimens, N3104 (His<sub>526</sub>
&#x005B;C<bold>A</bold>C&#x005D;&#x2192;Arg &#x005B;C<bold>G</bold>C&#x005D;), N3928 (wild
type), and N3983 (Ser<sub>531</sub> &#x005B;T<bold>T</bold>G&#x005D;&#x2192;Leu
&#x005B;T<bold>C</bold>G&#x005D;). Patterns of conventional PCR-SSCP using the TR9-TR8
primer set showed more than two bands (lanes P). They were unusual in PCR-SSCP
analysis performed with culture. However, nested PCR-SSCP showed only two bands
by which the rifampin resistance of <italic>M. tuberculosis</italic> could be determined
as other reports (lanes N). H, <italic>M. tuberculosis</italic>
H37Rv.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink"
xlink:href="jm0711435004" alt-version="yes"></graphic></fig><table-wrap
id="T3"><caption><p>Comparison of results determined by
three different methods to determine rifampin susceptibility of <italic>M.
tuberculosis</italic> in sputa and their culture
isolates</p></caption><table><tr><th rowspan="3">Specimen no.</th><th
rowspan="3">Clinical specimen designation</th><th colspan="4">Resistance to<xref
ref-type="table-fn" rid="TF3-A"></xref>:</th><th colspan="3">Result
from:</th></tr><tr><td colspan="4"><hr/></td><td
colspan="3"><hr/></td></tr><tr><th>RIF</th><th>INH</th><th>STR</th><th>EMB</th>
<th>Conventional PCR-SSCP or direct sequencing<xref ref-type="table-fn"
rid="TF3-B"></xref></th><th>Nested PCR-SSCP or direct sequencing<xref
ref-type="table-fn" rid="TF3-B"></xref></th><th>DNA sequencing</th></tr><tr><td
colspan="9"><hr/></td></tr><tr><td
align="center">1</td><td>N2838</td><td>S</td><td>S</td><td>S</td><td>S</td><td
align="left">Wild type</td><td align="left">Wild type</td><td align="left">No
mutation</td></tr><tr><td
align="center">2</td><td>N2872</td><td>S</td><td>S</td><td>S</td><td>S</td><td
align="left">Wild type</td><td align="left">Wild type</td><td align="left">No
mutation</td></tr><tr><td
align="center">3</td><td>N2877</td><td>R</td><td>R</td><td>S</td><td>R</td><td
align="left">Abnormal</td><td align="left">Abnormal</td><td
align="left">Mutation</td></tr><tr><td
align="center">4</td><td>N2893</td><td>R</td><td>R</td><td>S</td><td>R</td><td
align="left">Abnormal</td><td align="left">Abnormal</td><td
align="left">Mutation</td></tr><tr><td
align="center">5</td><td>N2895</td><td>R</td><td>R</td><td>S</td><td>S</td><td
align="left">Not determined<xref ref-type="table-fn" rid="TF3-C"></xref></td><td
align="left">Abnormal</td><td align="left">Mutation</td></tr><tr><td
align="center">6</td><td>N2902</td><td>R</td><td>R</td><td>S</td><td>R</td><td
align="left">Abnormal</td><td align="left">Abnormal</td><td
align="left">Mutation</td></tr><tr><td
align="center">7</td><td>N2903</td><td>R</td><td>R</td><td>S</td><td>R</td><td
align="left">Abnormal</td><td align="left">Abnormal</td><td
align="left">Mutation</td></tr><tr><td
align="center">8</td><td>N2904</td><td>S</td><td>S</td><td>S</td><td>S</td><td
align="left">Wild type</td><td align="left">Wild type</td><td align="left">No
mutation</td></tr><tr><td
align="center">9</td><td>N2910</td><td>R</td><td>R</td><td>R</td><td>R</td><td
align="left">Abnormal</td><td align="left">Abnormal</td><td
align="left">Mutation</td></tr><tr><td
align="center">10</td><td>N2984</td><td>R</td><td>R</td><td>S</td><td>S</td><td
align="left">Abnormal</td><td align="left">Abnormal</td><td
align="left">Mutation</td></tr><tr><td
align="center">11</td><td>N2994</td><td>S</td><td>S</td><td>S</td><td>S</td><td
align="left">Not determined</td><td align="left">Wild type</td><td
align="left">No mutation </td></tr><tr><td
align="center">12</td><td>N2999</td><td>S</td><td>S</td><td>S</td><td>S</td><td
align="left">Wild type</td><td align="left">Wild type</td><td align="left">No
mutation</td></tr><tr><td
align="center">13</td><td>N3000</td><td>S</td><td>S</td><td>S</td><td>S</td><td
align="left">Wild type</td><td align="left">Wild type</td><td align="left">No
mutation </td></tr><tr><td
align="center">14</td><td>N3012</td><td>S</td><td>S</td><td>S</td><td>S</td><td
align="left">Wild type</td><td align="left">Wild type</td><td align="left">No
mutation </td></tr><tr><td
align="center">15</td><td>N3085</td><td>S</td><td>S</td><td>S</td><td>S</td><td
align="left">Wild type</td><td align="left">Wild type</td><td align="left">No
mutation</td></tr><tr><td
align="center">16</td><td>N3096</td><td>S</td><td>S</td><td>S</td><td>S</td><td
align="left">Wild type</td><td align="left">Wild type</td><td align="left">No
mutation</td></tr><tr><td
align="center">17</td><td>N3104</td><td>R</td><td>R</td><td>R</td><td>S</td><td
align="left">Ambiguous<xref ref-type="table-fn" rid="TF3-D"></xref></td><td
align="left">Abnormal</td><td align="left">Mutation</td></tr><tr><td
align="center">18</td><td>N3105</td><td>S</td><td>S</td><td>S</td><td>S</td><td
align="left">Wild type</td><td align="left">Wild type</td><td align="left">No
mutation </td></tr><tr><td
align="center">19</td><td>N3106</td><td>S</td><td>S</td><td>S</td><td>S</td><td
align="left">Wild type</td><td align="left">Wild type</td><td align="left">No
mutation </td></tr><tr><td
align="center">20</td><td>N3426</td><td>S</td><td>S</td><td>S</td><td>S</td><td
align="left">Wild type</td><td align="left">Wild type</td><td align="left">No
mutation</td></tr><tr><td
align="center">21</td><td>N3428</td><td>S</td><td>S</td><td>S</td><td>S</td><td
align="left">Wild type</td><td align="left">Wild type</td><td align="left">No
mutation </td></tr><tr><td
align="center">22</td><td>N3440</td><td>R</td><td>R</td><td>S</td><td>R</td><td
align="left">Not determined</td><td align="left">Abnormal</td><td
align="left">Mutation</td></tr><tr><td
align="center">23</td><td>N3448</td><td>S</td><td>S</td><td>S</td><td>S</td><td
align="left">Not determined</td><td align="left">Wild type</td><td
align="left">No mutation</td></tr><tr><td
align="center">24</td><td>N3471</td><td>R</td><td>R</td><td>S</td><td>S</td><td
align="left">Abnormal</td><td align="left">Abnormal</td><td
align="left">Mutation</td></tr><tr><td
align="center">25</td><td>N3474</td><td>R</td><td>R</td><td>S</td><td>S</td><td
align="left">Abnormal</td><td align="left">Abnormal</td><td
align="left">Mutation</td></tr><tr><td
align="center">26</td><td>N3496</td><td>R</td><td>R</td><td>R</td><td>R</td><td
align="left">Abnormal</td><td align="left">Abnormal</td><td
align="left">Mutation</td></tr><tr><td
align="center">27</td><td>N3500</td><td>S</td><td>S</td><td>S</td><td>S</td><td
align="left">Wild type</td><td align="left">Wild type</td><td align="left">No
mutation</td></tr><tr><td
align="center">28</td><td>N3501</td><td>R</td><td>R</td><td>S</td><td>S</td><td
align="left">Abnormal</td><td align="left">Abnormal</td><td
align="left">Mutation</td></tr><tr><td
align="center">29</td><td>N3507</td><td>S</td><td>S</td><td>S</td><td>S</td><td
align="left">Wild type</td><td align="left">Wild type</td><td align="left">No
mutation</td></tr><tr><td
align="center">30</td><td>N3522</td><td>R</td><td>R</td><td>S</td><td>R</td><td
align="left">Abnormal</td><td align="left">Abnormal</td><td
align="left">Mutation</td></tr><tr><td
align="center">31</td><td>N3523</td><td>R</td><td>R</td><td>S</td><td>S</td><td
align="left">Abnormal</td><td align="left">Abnormal</td><td
align="left">Mutation</td></tr><tr><td
align="center">32</td><td>N3524</td><td>R</td><td>R</td><td>S</td><td>R</td><td
align="left">Abnormal</td><td align="left">Abnormal</td><td
align="left">Mutation</td></tr><tr><td
align="center">33</td><td>N3536</td><td>R</td><td>R</td><td>S</td><td>S</td><td
align="left">Abnormal</td><td align="left">Abnormal</td><td
align="left">Mutation</td></tr><tr><td
align="center">34</td><td>N3606</td><td>S</td><td>S</td><td>S</td><td>S</td><td
align="left">Wild type</td><td align="left">Wild type</td><td align="left">No
mutation</td></tr><tr><td
align="center">35</td><td>N3874</td><td>R</td><td>R</td><td>S</td><td>S</td><td
align="left">Abnormal</td><td align="left">Abnormal</td><td
align="left">Mutation</td></tr><tr><td
align="center">36</td><td>N3878</td><td>S</td><td>S</td><td>S</td><td>S</td><td
align="left">Wild type</td><td align="left">Wild type</td><td align="left">No
mutation </td></tr><tr><td
align="center">37</td><td>N3903</td><td>S</td><td>S</td><td>S</td><td>S</td><td
align="left">Not determined</td><td align="left">Wild type</td><td
align="left">No mutation </td></tr><tr><td
align="center">38</td><td>N3912</td><td>S</td><td>S</td><td>S</td><td>S</td><td
align="left">Not determined</td><td align="left">Wild type</td><td
align="left">No mutation</td></tr><tr><td
align="center">39</td><td>N3914</td><td>S</td><td>S</td><td>S</td><td>S</td><td
align="left">Wild type</td><td align="left">Wild type</td><td align="left">No
mutation </td></tr><tr><td
align="center">40</td><td>N3924</td><td>S</td><td>S</td><td>S</td><td>S</td><td
align="left">Wild type</td><td align="left">Wild type</td><td align="left">No
mutation</td></tr><tr><td
align="center">41</td><td>N3928</td><td>S</td><td>S</td><td>S</td><td>S</td><td
align="left">Ambiguous</td><td align="left">Wild type</td><td align="left">No
mutation</td></tr><tr><td
align="center">42</td><td>N3983</td><td>R</td><td>R</td><td>S</td><td>S</td><td
align="left">Ambiguous</td><td align="left">Abnormal</td><td
align="left">Mutation</td></tr><tr><td
align="center">43</td><td>N3986</td><td>R</td><td>R</td><td>S</td><td>R</td><td
align="left">Abnormal</td><td align="left">Abnormal</td><td
align="left">Mutation</td></tr><tr><td
align="center">44</td><td>N3990</td><td>S</td><td>S</td><td>S</td><td>S</td><td
align="left">Not determined</td><td align="left">Wild type</td><td
align="left">No mutation </td></tr><tr><td
align="center">45</td><td>N3992</td><td>S</td><td>S</td><td>S</td><td>S</td><td
align="left">Wild type</td><td align="left">Wild type</td><td align="left">No
mutation</td></tr><tr><td
align="center">46</td><td>N3993</td><td>S</td><td>S</td><td>S</td><td>S</td><td
align="left">Wild type</td><td align="left">Wild type</td><td align="left">No
mutation</td></tr><tr><td
align="center">47</td><td>N4025</td><td>R</td><td>R</td><td>S</td><td>R</td><td
align="left">Abnormal</td><td align="left">Abnormal</td><td
align="left">Mutation</td></tr><tr><td
align="center">48</td><td>N4030</td><td>R</td><td>R</td><td>R</td><td>R</td><td
align="left">Abnormal</td><td align="left">Abnormal</td><td
align="left">Mutation</td></tr><tr><td
align="center">49</td><td>N4062</td><td>S</td><td>S</td><td>S</td><td>S</td><td
align="left">Wild type</td><td align="left">Wild type</td><td align="left">No
mutation </td></tr><tr><td
align="center">50</td><td>N4064</td><td>S</td><td>S</td><td>S</td><td>S</td><td
align="left">Not determined</td><td align="left">Wild type</td><td
align="left">No mutation </td></tr><tr><td
align="center">51</td><td>N4069</td><td>S</td><td>R</td><td>S</td><td>R</td><td
align="left">Wild type</td><td align="left">Wild type</td><td align="left">No
mutation</td></tr><tr><td
align="center">52</td><td>N4115</td><td>R</td><td>R</td><td>S</td><td>S</td><td
align="left">Abnormal</td><td align="left">Abnormal</td><td
align="left">Mutation</td></tr><tr><td
align="center">53</td><td>N4116</td><td>S</td><td>S</td><td>S</td><td>S</td><td
align="left">Wild type</td><td align="left">Wild type</td><td align="left">No
mutation </td></tr><tr><td
align="center">54</td><td>N4123</td><td>S</td><td>S</td><td>S</td><td>S</td><td
align="left">Wild type</td><td align="left">Wild type</td><td align="left">No
mutation </td></tr><tr><td
align="center">55</td><td>N4159</td><td>S</td><td>S</td><td>S</td><td>S</td><td
align="left">Wild type</td><td align="left">Wild type</td><td align="left">No
mutation</td></tr><tr><td
align="center">56</td><td>N4165</td><td>S</td><td>S</td><td>S</td><td>S</td><td
align="left">Wild type</td><td align="left">Wild type</td><td align="left">No
mutation</td></tr></table><table-wrap-foot><fn id="TF3-A"><p>RIF, rifampin; INH,
isoniazid; STR, streptomycin; EMB, ethambutol; S, susceptible; R,
resistant.</p></fn><fn id="TF3-B"><p>Wild type or Abnormal, identical SSCP
patterns and sequences or different from that of reference strain,
respectively.</p></fn><fn id="TF3-C"><p>Products were poorly amplified for the
SSCP analysis.</p></fn><fn id="TF3-D"><p>The extra bands originating from other
bacteria which may coexist with <italic>M. tuberculosis</italic> interfered with SSCP
analysis.</p></fn></table-wrap-foot></table-wrap></sec>
<sec>
<title>Nested PCR-linked DNA
sequencing for sputa.</title>
<?mtl /hellip?><p><?mtl hellip?>We also applied both the conventional and the
nested PCR sequencing methods directly to sputa. The advantage of nested
PCR-linked sequencing was revealed when <italic>rpoB</italic> DNA from the three
specimens (N3104, N3928, and N3983) which had shown ambiguous results in
conventional PCR-SSCP was selectively amplified by nested PCR. Thus, mutations
related to rifampin resistance were definitely determined by direct sequencing.
It was interesting to note that the results of conventional PCR sequencing did
not coincide with those of nested PCR sequencing. The peaks on the
electropherogram of conventional PCR sequencing were confusing in one sample
(N3983) (Fig. <xref ref-type="fig" rid="F5">5</xref>, upper panel).
<?mtl /hellip?>The third nucleotide (CG<bold>A</bold>) at codon 529, which 
is a specific nucleotide of <italic>M. tuberculosis</italic> 
(<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" 
rid="B11">11</xref>), was not clearly determined by conventional PCR direct 
sequencing. Furthermore, PCR sequencing misidentified codon 531 as 
T<bold>C</bold>G, which reflects the rifampin-susceptible strain. However, 
the second nucleotide at codon 531, which is the most frequent site of
mutation related to rifampin resistance, was determined as 
T<bold>T</bold>G by nested PCR sequencing (Fig. <xref ref-type="fig" 
rid="F5">5</xref>, lower panel).<?mtl hellip?>The sequence analysis of <italic>rpoB</italic> DNA performed on a culture
isolate from the same sputum (N3983) showed a mutation at Ser<sub>531</sub>
(TCG&#x2192;T<bold>T</bold>G).
<?mtl /hellip?></p><?mtl hellip?>
<fig id="F5"><caption><p>Electropherograms of automatic DNA sequencing after the
amplification of <italic>rpoB</italic> DNA by PCR and nested PCR which were directly
performed with the DNA from sputum sample N3983. The PCR DNA sequencing (upper
panel) showed ambiguous results due to nonspecific amplification of
<italic>rpoB</italic> DNA. However, nested PCR DNA sequencing (lower panel) revealed a
signature nucleotide at codon 529 (CG<bold>A</bold>) and a mutation at codon 531
(T<bold>T</bold>G) in the <italic>rpoB</italic> DNA of <italic>M. tuberculosis</italic>. N3983 was
confirmed by susceptibility testing and sequence analysis of culture isolate as
a rifampin-resistant strain harboring a mutation at Ser<sub>531</sub>
(T<bold>C</bold>G&#x2192;T<bold>T</bold>G).</p></caption><graphic
xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jm0711435005"
alt-version="yes"></graphic></fig></sec><sec><title>Rifampin susceptibility of
culture isolates.</title><p>Culture isolates of <italic>M. tuberculosis</italic> from
sputa were analyzed in order to determine their rifampin susceptibility using
the agar dilution method and PCR direct sequencing. Results from the phenotypic
and genotypic analyses were identical. All the sequences determined by PCR
sequencing of culture isolates were concordant with those of sputa determined by
nested PCR sequencing but not with those determined by conventional PCR
sequencing.</p><p>Twenty-three strains displayed point mutations that are
correlated with rifampin resistance as determined by the agar dilution method.
Mutations in each codon of eight amino acids (Gln<sub>513</sub>,
Met<sub>515</sub>, Asp<sub>516</sub>, Gla<sub>517</sub>, Asn<sub>518</sub>,
His<sub>526</sub>, Ser<sub>531</sub>, and Leu<sub>533</sub>) were found. The
highest frequency (61&#x0025;) was observed at Ser<sub>531</sub>. Resistant
strains were also easily differentiated in a sequence-specific manner with the
PCR-SSCP analysis (Fig. <xref ref-type="fig" rid="F6">6</xref>). Interestingly,
novel genotypes were observed in two specimens. One strain (N3471) harbored 5
mutations (AT<bold>G</bold> G<bold>A</bold>C <bold>C</bold>A<bold>G A</bold>AC&#x2192;AT<bold>C</bold>
G<bold>C</bold>C <bold>A</bold>A<bold>C T</bold>AC) at four consecutive codons, which led to
changes of four amino acids
(Met<sub>515</sub>Asp<sub>516</sub>Gla<sub>517</sub>Asn<sub>518</sub>&#x2192;Ile
<sub>515</sub>Ala<sub>516</sub>Asn<sub>517</sub>Tyr<sub>518</sub>). The other
(N3522) harbored a double mutation (<bold>TC</bold>G&#x2192;<bold>AT</bold>G) at
Ser<sub>531</sub>. These two strains also showed novel SSCP patterns (Fig. <xref
ref-type="fig" rid="F6">6</xref>).</p><fig id="F6"><caption><p>Nested PCR-SSCP patterns of rifampin-resistant strains
(lanes 1 to 9) identified in this study. Lanes: H, <italic>M. tuberculosis</italic>
H37Rv; 1, N3523 (Gln<sub>513</sub>&#x2192;Pro); 2, N2893
(Asp<sub>516</sub>&#x2192;Val); 3, N2910 (His<sub>526</sub>&#x2192;Tyr); 4,
N3501 (His<sub>526</sub>&#x2192;Asp); 5, N2902 (His<sub>526</sub>&#x2192;Arg);
6, N2895 (Ser<sub>531</sub>&#x2192;Leu); 7, N3522
(Ser<sub>531</sub>&#x2192;Met); 8, N2877 (Leu<sub>533</sub>&#x2192;Pro); 9,
N3471 (Met<sub>515</sub>, Asp<sub>516</sub>, Gla<sub>517</sub>,
Asn<sub>518</sub>&#x2192;Ile, Ala, Asn, Tyr).</p></caption><graphic
xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jm0711435006"
alt-version="yes"></graphic></fig></sec></sec><sec
sec-type="discussion"><title>DISCUSSION</title><p>Missense mutations, usually confined to
the 69-nucleotide region of the <italic>rpoB</italic> gene, are related to the rifampin
resistance of <italic>M. tuberculosis</italic>. Using molecular techniques to detect
these mutations is more rapid than rifampin susceptibility testing which depends
on culture and therefore requires an additional 4 to 6 weeks after the primary
isolation to obtain the results. Although problems due to silent mutations were
recently described (<xref ref-type="bibr" rid="B12">12</xref>), rifampin
resistance in <italic>M. tuberculosis</italic> was successfully determined by PCR-SSCP
(<xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr"
rid="B15">15</xref>, <xref ref-type="bibr" rid="B21">21</xref>) and PCR direct
sequencing (<xref ref-type="bibr" rid="B11">11</xref>, <xref ref-type="bibr"
rid="B20">20</xref>) when the DNA was prepared from cultures. However, it has
not been easy to apply these methods directly to sputa because of the poor
sensitivity and specificity of PCR (<xref ref-type="bibr" rid="B8">8</xref>,
<xref ref-type="bibr" rid="B20">20</xref>). If PCR could be performed with sputa
as well as culture isolates, the entire identification process for <italic>M.
tuberculosis</italic> would be shortened to several days.</p><p>For this purpose, a
line probe assay (<xref ref-type="bibr" rid="B4">4</xref>) and single-tube
heminested PCR protocol (<xref ref-type="bibr" rid="B23">23</xref>) have been
developed. Although there are several advantages to the line probe assay, it is
more expensive than other methods and requires several probes for reverse
hybridization to determine the mutation. Heminested PCR uses signature
nucleotides of <italic>M. tuberculosis</italic> to avoid amplification of DNA from other
GC-rich bacteria. It is a powerful method to detect <italic>rpoB</italic> DNA of <italic>M.
tuberculosis</italic> directly from sputa. However, when this method was applied to
detect <italic>M. tuberculosis</italic> rifampin resistance, further analysis such as
sequencing or dideoxy fingerprinting after the amplification of 193-bp
<italic>rpoB</italic> DNA by heminested PCR was required. This method can be linked to
SSCP analysis performed directly on a DNA sample without a postamplification
step but, compared to SSCP analysis which targets the 157-bp <italic>rpoB</italic> DNA,
this method has problems in detecting several specific mutations. In order to
detect the most frequent mutation at codon 531 (Ser
&#x005B;T<bold>C</bold>G&#x005D;&#x2192;Leu &#x005B;T<bold>T</bold>G&#x005D;), it required
longer electrophoresis. Furthermore, the C-to-T transition mutation in codon 526
(His &#x005B;<bold>C</bold>AC&#x005D;&#x2192;Tyr &#x005B;<bold>T</bold>AC&#x005D;) was not
differentiated (<xref ref-type="bibr" rid="B6">6</xref>).</p><p>In this study,
we used a nested PCR strategy targeting the 157-bp <italic>rpoB</italic> DNA, which has
been most widely used for PCR-SSCP analysis and sequencing in order to detect
mutations related to rifampin resistance. This approach confers a higher
sensitivity and specificity than conventional PCR on SSCP and sequence analysis.
Unlike heminested PCR, which is based on limited numbers of mycobacterial
species (<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr"
rid="B23">23</xref>), the <italic>M. tuberculosis</italic>-specific primers for nested
PCR can be selected from the signature nucleotides on the basis of <italic>rpoB</italic>
DNA sequences of 44 mycobacteria (<xref ref-type="bibr" rid="B11">11</xref>).
Therefore, the possibility of nonspecific amplification of <italic>rpoB</italic> DNA
from NTM or nonmycobacteria should be greatly reduced. The signature nucleotides
for <italic>M. tuberculosis</italic> were located at the 3&#x2032; hydroxyl termini of
each primer as previously described (<xref ref-type="bibr" rid="B23">23</xref>).
Thus, amplification of <italic>rpoB</italic> DNA from NTM or nonmycobacteria could be
avoided by first-round PCR performed at a high annealing temperature and direct
detection and determination of the rifampin susceptibility of <italic>M.
tuberculosis</italic> in sputum were possible. Misidentification of <italic>rpoB</italic>
sequences (codons 529 and 531 of N3983) by PCR sequencing may have resulted from
simultaneous amplification of the <italic>rpoB</italic> DNA from <italic>M.
tuberculosis</italic> and other bacteria, but this problem was solved by the nested
PCR.</p><p>Conventional PCR-SSCP did not detect the <italic>rpoB</italic> sequences in
11 of 56 sputa (19.6&#x0025;). Although the <italic>rpoB</italic> DNAs were not
amplified (or detected) by conventional PCR in eight specimens, <italic>IS6110</italic>
PCR and cultures identified <italic>M. tuberculosis</italic> in all cases. Moreover,
nested PCR amplified <italic>rpoB</italic> DNA from these specimens, and thus permitted
rifampin susceptibilities to be determined by SSCP and sequencing. Another
example of the high specificity of nested PCR-SSCP was found in the results for
3 of the 11 specimens which showed ambiguous results by conventional PCR-SSCP.
Each had three bands that may have been caused by the simultaneous amplification
of the <italic>rpoB</italic> DNA from both <italic>M. tuberculosis</italic> and other bacteria.
Judging from SSCP patterns that were clearly different from that of the
rifampin-susceptible reference strain (<italic>M. tuberculosis</italic> H37Rv), they
might be regarded as rifampin resistant. Considering that NTM and
nonmycobacteria have sequence variations in the corresponding region (157 bp) of
amplified <italic>rpoB</italic> DNA, these bands may also represent false-positive
results. Nested PCR-SSCP and DNA sequencing definitively identified these
strains to be either rifampin-resistant or rifampin-susceptible <italic>M.
tuberculosis</italic>. In contrast, specimen N3928 was quite interesting in that it
was identified as a rifampin-resistant strain by PCR-SSCP but was proven to be
rifampin susceptible by nested PCR-SSCP, susceptibility testing, and PCR-direct
sequencing of <italic>rpoB</italic> DNA from pure culture. These results suggest that
<italic>rpoB</italic> amplification from bacteria other than <italic>M. tuberculosis</italic>,
causing a false-positive result, may be excluded by the nested PCR protocol used
in this study.</p><p>The results of the nested PCR-SSCP method applied to sputa
were entirely concordant with those of culture and conventional drug
susceptibility testing as well as those obtained by conventional PCR-SSCP
analysis. Furthermore, nested PCR-SSCP analysis enabled the direct detection of
rifampin resistance from primary clinical specimens, such as sputa. Although the
nested PCR-SSCP has a great advantage in reducing the time required for the
primary culture and specific identification of <italic>M. tuberculosis</italic> in
sputa, it still is limited by the requirements of radiolabeled PCR products,
extensive labor, and a level of technical expertise not found in most clinical
laboratories. It does, however, provide a significant advance in the rapid
detection of multidrug-resistant <italic>M. tuberculosis</italic> directly from a
clinical specimen.</p></sec></body><back><ack><title>ACKNOWLEDGMENTS</title><p>This
work was supported by grant 98-N1-02-01-A-08 from the National Project for
Medical Research, funded by the Korean Ministry of Science and Technology
(MOST), and supported in part by project BK21 for Medicine, Dentistry, and
Pharmacy.</p></ack><ref-list><title>REFERENCES</title><ref
id="B1"><citation><name><surname>Barnes</surname><given-names>P.</given-names></name>
<name><surname>Bloch</surname><given-names>A. B.</given-names></name><name><surname>Davidson</surname><given-names>P.
T.</given-names></name><name><surname>Snider</surname><given-names>D.
E.</given-names><suffix>Jr.</suffix></name><article-title>Tuberculosis in patients with
immunodeficiency virus infection</article-title><source>N. Engl. J.
Med.</source><year>1991</year><volume>324</volume><fpage>1644</fpage><lpage>1650
</lpage></citation></ref><ref
id="B2"><citation><name><surname>Boom</surname><given-names>R.</given-names></name>
<name><surname>Sol</surname><given-names>C. J. A.</given-names></name><name><surname>Salimans</surname><given-names>M.
M. M.</given-names></name><name><surname>Jansen</surname><given-names>C.
L.</given-names></name><name><surname>Wertheim-van Dillen</surname><given-names>P. M.
E.</given-names></name><name><surname>Van Der
Noordaa</surname><given-names>J.</given-names></name><article-title>Rapid and simple method for
purification of nucleic acids</article-title><source>J. Clin.
Microbiol.</source><year>1990</year><volume>28</volume><fpage>495</fpage><lpage>
503</lpage></citation></ref><ref
id="B3"><citation><collab>British Thoracic
Association</collab><article-title>A controlled trial of six months chemotherapy in
pulmonary tuberculosis</article-title><source>Am. Rev. Respir.
Dis.</source><year>1982</year><volume>126</volume><fpage>460</fpage><lpage>462
</lpage></citation></ref><ref
id="B4"><citation><name><surname>De
Beenhouwer</surname><given-names>H.</given-names></name><name><surname>Lhiang</surname><given-names>Z.</given-names>
</name><name><surname>Jannes</surname><given-names>G.</given-names></name><name><surname>Mijs</surname><given-names>W.
</given-names></name><name><surname>Machtelinckx</surname><given-names>L.</given-names></name><name><surname>
Rossau</surname><given-names>R.</given-names></name><name><surname>Traore</surname><given-names>H.</given-names></name>
<name><surname>Portalels</surname><given-names>F.</given-names></name><article-title>Rapid detection of
rifampin resistance in sputum and biopsy specimens from tuberculosis patients by
PCR and line probe assay</article-title><source>Tuber. Lung
Dis.</source><year>1995</year><volume>76</volume><fpage>425</fpage><lpage>430
</lpage></citation></ref><ref
id="B5"><citation><name><surname>Des Prez</surname><given-names>R.
M.</given-names></name><name><surname>Heim</surname><given-names>C.
R.</given-names></name><name><surname>Mandell</surname><given-names>G.
L.</given-names></name><name><surname>Douglas</surname><given-names>R.
G.</given-names></name><name><surname>Bennett</surname><given-names>J.
E.</given-names></name><article-title><italic>Mycobacterium
tuberculosis</italic></article-title><source>Principles and practice of infectious
diseases</source><year>1990</year><edition>2nd ed.</edition><publisher-loc>New York,
N.Y</publisher-loc><publisher-name>
Churchill Livingstone</publisher-name><fpage>1877</fpage><lpage>1906</lpage></citation></ref><ref
id="B6"><citation><name><surname>Felmlee</surname><given-names>T.
A.</given-names></name><name><surname>Liu</surname><given-names>Q.</given-names></name><name><surname>Whelen</surname
><given-names>A.
C.</given-names></name><name><surname>Williams</surname><given-names>D.</given-names></name><name><surname>Sommer
</surname><given-names>S. S.</given-names></name><name><surname>Persing</surname><given-names>D.
H.</given-names></name><article-title>Genotypic detection of <italic>Mycobacterium
tuberculosis</italic> rifampin resistance: comparison of single-strand conformation
polymorphism and dideoxy fingerprinting</article-title><source>J. Clin.
Microbiol.</source><year>1995</year><volume>33</volume><fpage>1617</fpage><lpage
>1623</lpage></citation></ref><ref
id="B7"><citation><name><surname>Frieden</surname><given-names>T.
R.</given-names></name><name><surname>Sterling</surname><given-names>T.</given-names></name><name><surname>Pablos
-Mendez</surname><given-names>A.</given-names></name><name><surname>Kilburn</surname><given-names>J.
O.</given-names></name><name><surname>Cauthen</surname><given-names>J.
O.</given-names></name><name><surname>Dooley</surname><given-names>S. W.</given-names></name><article-title>The
emergence of drug-resistant tuberculosis in New York City</article-title><source>N.
Engl. J.
Med.</source><year>1993</year><volume>328</volume><fpage>521</fpage><lpage>526
</lpage></citation></ref><ref
id="B8"><citation><name><surname>Hunt</surname><given-names>J.
M.</given-names></name><name><surname>Roberts</surname><given-names>G.
D.</given-names></name><name><surname>Stockmann</surname><given-names>L.</given-names></name><name><surname>
Felmlee</surname><given-names>T. A.</given-names></name><name><surname>Persing</surname><given-names>D.
D.</given-names></name><article-title>Detection of a genetic locus encoding resistance to
rifampin in mycobacterial cultures and in clinical
specimens</article-title><source>Diagn. Microbiol. Infect.
Dis.</source><year>1994</year><volume>18</volume><fpage>219</fpage><lpage>227
</lpage></citation></ref><ref
id="B9"><citation><name><surname>Iseman</surname><given-names>M.</given-names></name><article-title>Treatment of multidrug-resistant tuberculosis</article-title><source>N. Engl. J. Med.</source><year>1993</year><volume>329</volume><fpage>784</fpage><lpage>791
</lpage></citation></ref><ref
id="B10"><citation><name><surname>Jin</surname><given-names>D.</given-names></name>
<name><surname>Gross</surname><given-names>C. A.</given-names></name><article-title>Mapping and sequencing of
mutations in the <italic>Escherichia coli rpoB</italic> gene that lead to rifampicin
resistance</article-title><source>J. Mol.
Biol.</source><year>1988</year><volume>202</volume><fpage>45</fpage><lpage>58
</lpage></citation></ref><ref
id="B11"><citation><name><surname>Kim</surname><given-names>B.
J.</given-names></name><name><surname>Lee</surname><given-names>S.
H.</given-names></name><name><surname>Lyu</surname><given-names>M.
A.</given-names></name><name><surname>Kim</surname><given-names>S.
J.</given-names></name><name><surname>Bai</surname><given-names>G.
H.</given-names></name><name><surname>Kim</surname><given-names>S.
J.</given-names></name><name><surname>Chae</surname><given-names>G.
T.</given-names></name><name><surname>Kim</surname><given-names>E.
C.</given-names></name><name><surname>Cha</surname><given-names>C.
Y.</given-names></name><name><surname>Kook</surname><given-names>Y.
H.</given-names></name><article-title>Identification of mycobacterial species by comparative
sequence analysis of the RNA polymerase gene (<italic>rpoB</italic>)</article-title><source>J.
Clin.
Microbiol.</source><year>1999</year><volume>37</volume><fpage>1714</fpage><lpage
>1720</lpage></citation></ref><ref
id="B12"><citation><name><surname>Kim</surname><given-names>B.
J.</given-names></name><name><surname>Kim</surname><given-names>S.
Y.</given-names></name><name><surname>Park</surname><given-names>B.
H.</given-names></name><name><surname>Lyu</surname><given-names>M.
A.</given-names></name><name><surname>Park</surname><given-names>I.
K.</given-names></name><name><surname>Bai</surname><given-names>G.
H.</given-names></name><name><surname>Kim</surname><given-names>S.
J.</given-names></name><name><surname>Cha</surname><given-names>C.
Y.</given-names></name><name><surname>Kook</surname><given-names>Y. H.</given-names></name><article-title>Mutations
in the <italic>rpoB</italic> gene of <italic>Mycobacterium tuberculosis</italic> that interfere
with PCR-single-strand-conformation polymorphism analysis for rifampin
susceptibility testing</article-title><source>J. Clin.
Microbiol.</source><year>1997</year><volume>35</volume><fpage>492</fpage><lpage>
494</lpage></citation></ref><ref
id="B13"><citation><name><surname>Kim</surname><given-names>S.
J.</given-names></name><name><surname>Hong</surname><given-names>Y. P.</given-names></name><article-title>Drug
resistance of <italic>Mycobacterium tuberculosis</italic> in
Korea</article-title><source>Tuber. Lung
Dis.</source><year>1992</year><volume>73</volume><fpage>219</fpage><lpage>224
</lpage></citation></ref><ref
id="B14"><citation><name><surname>Lisitsyn</surname><given-names>N.
A.</given-names></name><name><surname>Sverdlov</surname><given-names>E.
D.</given-names></name><name><surname>Moiseyeva</surname><given-names>E.
P.</given-names></name><name><surname>Danilevskaya</surname><given-names>O.
N.</given-names></name><name><surname>Nikiforov</surname><given-names>V.
G.</given-names></name><article-title>Mutation to rifampin resistance at the beginning of the
RNA polymerase beta subunit gene in <italic>Escherichia
coli</italic></article-title><source>Mol. Gen.
Genet.</source><year>1984</year><volume>196</volume><fpage>173</fpage><lpage>174
</lpage></citation></ref><ref
id="B15"><citation><name><surname>Matsiota-Bernard</surname><given-names>P.
</given-names></name><name><surname>Vrioni</surname><given-names>G.</given-names></name><name><surname>Marinis</surname
><given-names>E.</given-names></name><article-title>Characterization of <italic>rpoB</italic> mutations in
rifampin-resistant clinical <italic>Mycobacterium tuberculosis</italic> isolates from
Greece</article-title><source>J. Clin.
Microbiol</source><year>1998</year><volume>36</volume><fpage>20</fpage><lpage>23
</lpage></citation></ref><ref
id="B16"><citation><name><surname>Mitchison</surname><given-names>D.
A.</given-names></name><name><surname>Nunn</surname><given-names>A. J.</given-names></name><article-title>Influence
of initial drug resistance on the response to short-course chemotherapy of
pulmonary tuberculosis</article-title><source>Am. Rev. Respir.
Dis.</source><year>1986</year><volume>133</volume><fpage>423</fpage><lpage>430
</lpage></citation></ref><ref
id="B17"><citation><name><surname>Morris</surname><given-names>S.</given-names></name
><name><surname>Bai</surname><given-names>G.
H.</given-names></name><name><surname>Suffys</surname><given-names>P.</given-names></name><name><surname>Portillo
-Gomez</surname><given-names>L.</given-names></name><name><surname>Fairchok</surname><given-names>M.</given-names></name
><name><surname>Rouse</surname><given-names>D.</given-names></name><article-title>Molecular mechanisms of
multiple drug resistance in clinical isolates of <italic>Mycobacterium
tuberculosis</italic></article-title><source>J. Infect.
Dis.</source><year>1995</year><volume>171</volume><fpage>954</fpage><lpage>960
</lpage></citation></ref><ref
id="B18"><citation><name><surname>Nolte</surname><given-names>F.
S.</given-names></name><name><surname>Metchock</surname><given-names>B.</given-names></name><name><surname>Murray</surname><given-names>P.
R.</given-names></name><name><surname>Baron</surname><given-names>E.
J.</given-names></name><name><surname>Pfaller</surname><given-names>M.
A.</given-names></name><name><surname>Tenover</surname><given-names>F.
C.</given-names></name><name><surname>Yolken</surname><given-names>R.
H.</given-names></name><article-title><italic>
Mycobacterium</italic></article-title><source>Manual of clinical
microbiology.</source><year>1995</year><publisher-loc>Washington,
D.C.</publisher-loc><publisher-name>
American Society for Microbiology</publisher-name><fpage>400</fpage><lpage>437</lpage></citation></ref><ref
id="B19"><citation><name><surname>Roberts</surname><given-names>G.
D.</given-names></name><name><surname>Goodman</surname><given-names>N.
L.</given-names></name><name><surname>Heifets</surname><given-names>L.</given-names></name><name><surname>Larsh
</surname><given-names>H. W.</given-names></name><name><surname>Lindner</surname><given-names>T.
H.</given-names></name><name><surname>McClatchy</surname><given-names>J.
K.</given-names></name><name><surname>McGinnis</surname><given-names>M.
R.</given-names></name><name><surname>Siddiqi</surname><given-names>S.
H.</given-names></name><name><surname>Wright</surname><given-names>P.</given-names></name><article-title>Evaluation
of the BACTEC radiometric method for recovery of mycobacteria and drug
susceptibility testing of <italic>Mycobacterium tuberculosis</italic> from acid-fast
smear-positive specimens</article-title><source>J. Clin.
Microbiol.</source><year>1983</year><volume>18</volume><fpage>689</fpage><lpage>
696</lpage></citation></ref><ref
id="B20"><citation><name><surname>Telenti</surname><given-names>A.</given-names>
</name><name><surname>Imboden</surname><given-names>P.</given-names></name><name><surname>Marchesi</surname>
<given-names>F.</given-names></name><name><surname>Lowrie</surname><given-names>D.</given-names></name><name><surname>
Cole</surname><given-names>S.</given-names></name><name><surname>Colston</surname><given-names>M.
J.</given-names></name><name><surname>Matter</surname><given-names>L.</given-names></name><name><surname>Schopfer
</surname><given-names>K.</given-names></name><name><surname>Bodmer</surname><given-names>T.</given-names></name><article-title>Detection of rifampin-resistance mutations in <italic>Mycobacterium
tuberculosis</italic></article-title><source>Lancet</source><year>1993
</year><volume>341</volume><fpage>647</fpage><lpage>650</lpage></citation></ref><ref
id="B21"><citation><name><surname>Telenti</surname><given-names>A.</given-names>
</name><name><surname>Imboden</surname><given-names>P.</given-names></name><name><surname>Marchesi</surname>
<given-names>F.</given-names></name><name><surname>Schmidheini</surname><given-names>T.</given-names></name><name>
<surname>Bodmer</surname><given-names>T.</given-names></name><article-title>Direct, automated detection of
rifampin-resistant <italic>Mycobacterium tuberculosis</italic> by polymerase chain
reaction and single-strand conformation polymorphism
analysis</article-title><source>Antimicrob. Agents
Chemother.</source><year>1993</year><volume>37</volume><fpage>2054</fpage><lpage
>2058</lpage></citation></ref><ref
id="B22"><citation><name><surname>Thierry</surname><given-names>D.</given-names>
</name><name><surname>Cave</surname><given-names>M.
D.</given-names></name><name><surname>Gsenach</surname><given-names>K.
D.</given-names></name><name><surname>Crawford</surname><given-names>J.
T.</given-names></name><name><surname>Bates</surname><given-names>J.
H.</given-names></name><name><surname>Gloquel</surname><given-names>B.</given-names></name><name><surname>Guesdon
</surname><given-names>J. L.</given-names></name><article-title>IS6110, an IS-like element of
<italic>Mycobacterium tuberculosis</italic> complex</article-title><source>Nucleic Acids
Res.</source><year>1990</year><volume>18</volume><fpage>188</fpage></citation></ref><ref
id="B23"><citation><name><surname>Whelen</surname><given-names>A.
C.</given-names></name><name><surname>Felmlee</surname><given-names>T.
A.</given-names></name><name><surname>Hunt</surname><given-names>J.
M.</given-names></name><name><surname>Wiliams</surname><given-names>D.
L.</given-names></name><name><surname>Roberts</surname><given-names>G.
D.</given-names></name><name><surname>Stockman</surname><given-names>L.</given-names></name><name><surname>
Persing</surname><given-names>D. H.</given-names></name><article-title>Direct genotypic detection of
<italic>Mycobacterium tuberculosis</italic> rifampin resistance in clinical specimens by
using single-tube heminested PCR</article-title><source>J. Clin.
Microbiol.</source><year>1995</year><volume>33</volume><fpage>556</fpage><lpage>
561</lpage></citation></ref></ref-list></back></article> <?mtl /hellip?>
